Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Escobar

Showing results (81-90 of 368) with videos related to

Pageof 37
Sort By:
Circulation|February 10, 2010
Letter by Barrios et al regarding article, "Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women"Vivencio Barrios, Carlos Escobar, Rocio Echarri
Journal of Atrial Fibrillation|May 13, 2017
Atrial Fibrillation And Coronary Heart Disease:Fatal AttractionVivencio Barrios, Carlos Escobar, Rocio Echarri
Vascular Health and Risk Management|October 2, 2008
Relative safety profiles of high dose statin regimensCarlos Escobar, Rocio Echarri, Vivencio Barrios
Archives of Internal Medicine|June 25, 2008
Concomitance of cardiovascular comorbidities in the hypertensive population: not only in the United StatesVivencio Barrios, Carlos Escobar, Rocio Echarri
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|September 24, 2011
Are general blood pressure targets still valid?Carlos Escobar, Vivencio Barrios, Rocio Echarri
Journal of Clinical Hypertension (Greenwich, Conn.)|July 4, 2012
Atrial fibrillation and hypertension: do new anticoagulants change the matter?Vivencio Barrios, Carlos Escobar, Alberto Calderon
Circulation|November 4, 2009
Letter by Barrios et al regarding article, "Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study"Vivencio Barrios, Carlos Escobar, Rocio Echarri
ESC Heart Failure|December 27, 2019
Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?Carlos Escobar, Vivencio Barrios, Luis Manzano
Obesity (Silver Spring, Md.)|February 6, 2010
Clinical profile and management of patients with hypertension and chronic ischemic heart disease according to BMIVivencio Barrios, Carlos Escobar, Alberto Calderón
Fundamental & Clinical Pharmacology|March 21, 2009
Importance of medication adherence from the ONTARGET and TRANSCEND points of viewVivencio Barrios, Carlos Escobar, Rocio Echarri
Pageof 37

Showing results (81-90 of 368) with videos related to

Sort By:
Pageof 37
Circulation|February 10, 2010
Letter by Barrios et al regarding article, "Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women"Vivencio Barrios, Carlos Escobar, Rocio Echarri
Journal of Atrial Fibrillation|May 13, 2017
Atrial Fibrillation And Coronary Heart Disease:Fatal AttractionVivencio Barrios, Carlos Escobar, Rocio Echarri
Vascular Health and Risk Management|October 2, 2008
Relative safety profiles of high dose statin regimensCarlos Escobar, Rocio Echarri, Vivencio Barrios
Archives of Internal Medicine|June 25, 2008
Concomitance of cardiovascular comorbidities in the hypertensive population: not only in the United StatesVivencio Barrios, Carlos Escobar, Rocio Echarri
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|September 24, 2011
Are general blood pressure targets still valid?Carlos Escobar, Vivencio Barrios, Rocio Echarri
Journal of Clinical Hypertension (Greenwich, Conn.)|July 4, 2012
Atrial fibrillation and hypertension: do new anticoagulants change the matter?Vivencio Barrios, Carlos Escobar, Alberto Calderon
Circulation|November 4, 2009
Letter by Barrios et al regarding article, "Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study"Vivencio Barrios, Carlos Escobar, Rocio Echarri
ESC Heart Failure|December 27, 2019
Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?Carlos Escobar, Vivencio Barrios, Luis Manzano
Obesity (Silver Spring, Md.)|February 6, 2010
Clinical profile and management of patients with hypertension and chronic ischemic heart disease according to BMIVivencio Barrios, Carlos Escobar, Alberto Calderón
Fundamental & Clinical Pharmacology|March 21, 2009
Importance of medication adherence from the ONTARGET and TRANSCEND points of viewVivencio Barrios, Carlos Escobar, Rocio Echarri
Pageof 37